4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10920 |
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
|
Others | Others |
Arg-Gly-Asp-D-Phe-Val (TFA) has anti-tumor activity and is an inhibitor of integrin αvβ3. | |||
T82643 |
cyclo(Phe-Ala-Gly-Arg-Arg-Arg-Gly-AEEAc)
|
||
Cyclo(Phe-Ala-Gly-Arg-Arg-Arg-Gly-AEEAc) 通过抑制 GRTH/DDX25 的磷酸化,展现了其作为非激素性男性避孕药开发的潜在途径。 | |||
T75990 |
Cyclo(Arg-Gly-Asp-D-Phe-Val)
|
||
Cyclo(Arg-Gly-Asp-D-Phe-Val) 为一种整合素αvβ3抑制剂,具有抗肿瘤活性,并可用于急性髓系白血病的研究。 | |||
T76068 |
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA
|
||
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA 是一种环状RGD多肽, 对αvβ3有高亲和性,能干扰细胞整合素之间的相互作用。此化合物能抑制胚胎干细胞(ESC)的多潜能性基因表达,并可在体内减少mESC的致瘤潜力,因此适用于肿瘤研究领域。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN6682 | Cyclo(Phe-Gly) | ||
Cyclo(Phe-Gly) shows weak antagonistic activity against VEGFR2 -CD, it also shows strong inhibitory activity against human cancer cells(KB,KBv200) with LD50 at 6.5 and 11.2 umol/L,respectively. |